Abstract
Patients with Alzheimer's disease whose psychotic symptoms improved with use of pimavanserin also showed improvement in agitation and aggression compared with nonresponders to the treatment, a study has found. These differences on agitation and aggression also were apparent in patients with higher baseline levels of these symptoms, the researchers reported.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
